Status:
COMPLETED
Obesity in Pediatric Sickle Cell Disease: A New Phenomenon
Lead Sponsor:
University of Mississippi Medical Center
Conditions:
Sickle Cell Disease
Obesity, Childhood
Eligibility:
All Genders
10-19 years
Brief Summary
The objective of this project is to determine the prevalence of hypertension, hyperlipidemia and hyperglycemia in the pediatric population with sickle cell disease who are obese in Mississippi compare...
Detailed Description
SIGNIFICANCE Sickle Cell Disease (SCD) is the most common genetic disorder in the world and in the United States (U.S.), with about 1 in 13 African Americans born with sickle cell trait and approximat...
Eligibility Criteria
Inclusion
- 10-19 years
- diagnosed with SCD genotype HbSS, HbSβ0, HbSC, or HbSβ+
- regularly followed by the UMMC Pediatric SCD clinic (i.e., average visit at least once per year in past two years)
Exclusion
- non-English speaking
- patient in acute vaso-occlusive pain crisis (which can increase blood pressure)
- cognitive or developmental delays that preclude ability to complete study questionnaires
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04676113
Start Date
March 1 2021
End Date
June 30 2022
Last Update
May 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Mississippi Medical Center
Jackson, Mississippi, United States, 39216